Characteristics and therapeutic management of patients with relapsing-remitting multiple sclerosis - data from a French multiple sclerosis population-based registry (the Multiple Sclerosis Registry in Lorraine Region)

被引：0
|
作者：
Epstein, J. [1 ]
Mathey, G. [1 ]
Guillemin, F. [1 ]
Debouverie, M. [1 ]
Tehard, B. [2 ]
Bitoun, L. [2 ]
Depoortere, P-H. [2 ]
机构：
[1] CHRU Nancy, Nancy, France
[2] Roche France, Boulogne, France
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1339
引用
收藏
页码：711 / 711
页数：1
相关论文
共 50 条
  • [21] A Retrospective Analysis in Patients with Relapsing-Remitting Multiple Sclerosis - Results of the Data Collection in Multiple Sclerosis "TYPIC"
    Maurer, Mathias
    Schicklmaier, Petra
    Niemczyk, Gabriele
    Schwab, Stefan
    NEUROLOGY, 2009, 72 (11) : A235 - A235
  • [22] Rituximab for relapsing-remitting multiple sclerosis
    He, Dian
    Zhou, Hongyu
    Han, Wenjie
    Zhang, Shihong
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12):
  • [23] The prevalence of comorbidities in patients with multiple sclerosis: population-based registry data
    Maric, Gorica D.
    Pekmezovic, Tatjana D.
    Mesaros, Sarlota T.
    Tamas, Olivera S.
    Ivanovic, Jovana B.
    Martinovic, Vanja N.
    Andabaka, Marko M.
    Jovanovic, Aleksa Lj.
    Veselinovic, Nikola D.
    Kisic-Tepavcevic, Darija B.
    Drulovic, Jelena S.
    NEUROLOGICAL SCIENCES, 2021, 42 (05) : 1887 - 1893
  • [24] The prevalence of comorbidities in patients with multiple sclerosis: population-based registry data
    Gorica D. Maric
    Tatjana D. Pekmezovic
    Sarlota T. Mesaros
    Olivera S. Tamas
    Jovana B. Ivanovic
    Vanja N. Martinovic
    Marko M. Andabaka
    Aleksa Lj. Jovanovic
    Nikola D. Veselinovic
    Darija B. Kisic-Tepavcevic
    Jelena S. Drulovic
    Neurological Sciences, 2021, 42 : 1887 - 1893
  • [25] Therapeutic management of relapsing-remitting multiple sclerosis in France in the recent era
    Leray, E.
    Casey, R.
    Rollot, F.
    El Bahi, I.
    Bastien, A.
    Raponi, E.
    Durand, B.
    Vukusic, S.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 695 - 695
  • [26] Safety of teriflunomide for the management of relapsing-remitting multiple sclerosis
    Papadopoulou, Athina
    Kappos, Ludwig
    Sprenger, Till
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (05) : 749 - 759
  • [27] Is it multiple sclerosis or not? - When relapsing-remitting multiple sclerosis is associated to Sidgren syndrome
    Gouider-Khouja, N
    Dkhili, A
    Khanfir, I
    El Euch-Fayache, G
    Houman, H
    Hentati, E
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S191 - S191
  • [28] NEDA as a predictor of conversion to secondary progressive multiple sclerosis in patients with relapsing-remitting multiple sclerosis
    Kappos, L.
    Stefano, N. D.
    Sormani, M. P.
    Giovannoni, G.
    Haring, D.
    Tomic, D.
    Meier, D. Piani
    Chitnis, T.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 638 - 639
  • [29] Clinical parameters at multiple sclerosis diagnosis and cognitive performance in relapsing-remitting multiple sclerosis patients
    Anabel Silva, Berenice
    Laura Saladino, Maria
    Eizaguirre, Barbara
    Alonso, Ricardo
    Cecilia Pita, Maria
    Merino, Angeles
    Yastremiz, Cecilia
    Cabral, Nadia
    Mariangeli, Aldana
    Vanotti, Sandra
    Garcea, Orlando
    Caceres, Fernando
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (01) : 151 - 152
  • [30] MICROBIOME CORE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Navarro-Lopez, V.
    Mingot, J. M.
    Carrion-Gutierrez, M.
    Paya-Espinosa, Y.
    Ruzafa Costa, B.
    Nunez Delegido, E.
    ANNALS OF NUTRITION AND METABOLISM, 2018, 72 : 56 - 57
12345